Myxredlin

Active Ingredient(s): Insulin Human
FDA Approved: * June 20, 2019
Pharm Company: * CELERITY PHARMS
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Myxredlin Overview

Insulin is a protein hormone that is used as a medication to treat high blood glucose.[3] This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states.[3] It is also used along with glucose to treat high blood potassium levels.[4] Typically it is given by injection under the skin, but some forms may also be used by inje...

Read more Myxredlin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_(medication)

Recent Myxredlin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Insulin Human
  • Solution: 100 Units/100ml (1 Unit/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Myxredlin: (1 result)

Sorted by National Drug Code
  • 0338-0126 Myxredlin 1 [Iu]/Ml Intravenous Injection, Solution by Baxter Healthcare Corporation

Other drugs which contain Insulin Human or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA